Who
R. Scott Huennekens
Director
Company insider
Files Form 4 as: Director, QuidelOrtho; Director, Neuropace; Director, Envista Holdings; Director, Hyperfine; Director, Nuvasive; Director, Acutus Medical; Director, ViewRay; Director, REVA Medical.
In numbers
- Trades disclosed
- 744
- Buys
- 0
- Sells
- 76
- Bought
- $0
- Sold
- $33.0M
- Companies
- 11
- Companies where not an officer
- 10
- First trade
- 16 Nov 2006
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,532 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,532 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | —2,890 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,368 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,368 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | —2,890 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code A | —6,829 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —6,829 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —6,829 at $0.00 | filing |
| 29 May 2026filed 2 Jun 2026 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code A | —6,829 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —12,585 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —12,585 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —14,370 at $0.00 | filing |
| 6 Jun 2025filed 9 Jun 2025 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —8,745 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —6,829 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | QDEL QuidelOrthooption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,523 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | QDEL QuidelOrthoDiagnostics & Labs | SEC FORM 4 Code A | —2,523 at $0.00 | filing |
| 6 Jan 2025filed 8 Jan 2025 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —15,507 at $0.00 | filing |
| 12 Jun 2024filed 12 Jun 2024 | HYPR Hyperfineoption or derivative · Medical Devices | SEC FORM 4 Code A | —79,200 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —14,170 at $0.00 | filing |
The newest 500 lines are listed; the numbers count every line.
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.